Cost benefits from improving clinical outcome

Infections in Medicine

Volumn 15, Issue 8 SUPPL. E, 1998, Pages 61-67

  Vogel, Friedrich ^a,b  

^a Kliniken des Main Taunus Kreises   (Germany)

^b Med Klinik III   (Germany)

Author keywords

Acute bacterial exacerbation of chronic bronchitis (ABECB); Clinical outcome; Community acquired pneumonia (CAP); Health care costs; Lower respiratory tract infection (LRTI); Pharmacoeconomics; Treatment failure

Indexed keywords

EID: 0001988971     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fine MJ, Orloff J, Arisumi D, et al: Prognosis of patients hospitalised with CAP. Am J Med 88:5, 1990.
2. Fine MJ, Auble TE, Yealy DM, et al: A prediction rule to identity low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243-250, 1997.
3. Fang GD, Fine M, Orloff J, et al: New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 69(5):307, 1990.
4. National Drug Therapeutic Index. Fairview, NJ, IMS/Clarke O'Neill (Dun and Bradstreet), 1991.
5. Schaberg T, Gialdoni-Grassi G, Huchon G, et al: An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. Thorax 51:1017-1022, 1996.
6. Marrie TJ: Community acquired pneumonia. Clin Infect Dis 18:501-511, 1994.
7. Lovering A, Fenney R, Brown I, et al: Resource utilisation for patients hospitalised with community-acquired chest infection. Eur Resp J 10(suppl 25):1733s, 1997.
8. Guest JF, Morris A: Community-acquired pneumonia: The annual cost to the National Health Service in the UK. Eur Respir J 10(7):1530-1534, 1997.
9. Konietzko N, Fabel H (eds): The German Whitebook. New York, Thieme Stuttgart, 1996.
10. Gladen HE: Computer modelling antibiotic therapy costs: Impact of therapeutic range. Drugs 35(suppl 2):S208-S213, 1988.
11. Backhouse RJ, Kapasi M, Noble I, et al: Modelling the use of three antibiotics in the management of community acquired pneumonia. Br J Med Econ 8:195-210, 1995.
12. Backhouse R, Shakespeare A, Hutton J: Economic evaluation of alternative antibiotic regimens in the management of acute exacerbations of chronic bronchitis. Br J Med Econ 8:11-25, 1995.
13. Wool C, Cerutti R, Garbagna N, et al: A cost-effective study of four different antibiotics in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Br J Med Econ 10:159-168, 1996.
14. nd European Congress on Anti-infective Agents and Chemotherapy, 1998. Abstract T147, p 72.
15. Guest JF, Morris A: Community-acquired lower respiratory tract infections: The annual cost to the National Health Service. Br J Med Econ 10(3):263-273, 1996.
16. Davey P: Cost effectiveness of once-daily oral antimicrobial therapy. J Clin Pharmacol 32:706-710, 1992.
17. Atkinson HE, Chambers ST, McGinlay, AM: Antibiotic therapy costs. N Z Med J 102:409-411, 1989.
18. Gruneberg RN, Felmingham D: Results of the Alexander Project: A continuing multicentre study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 25:169-181, 1996.
19. Venkatesan P, Innes JA: Antibiotic resistance in common acute respiratory pathogens. Thorax 50:481-483, 1995.
20. Washington JA: A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. The Alexander Project. Diagn Microbiol Infect Dis 25:183-190, 1996.
21. University of Houston College of Pharmacy Center for pharmaceutical care of the elderly Web site. http:pharmacy.uh.edu/Centers/ CenterElderly.html.
22. Vogel F, Luth A, Charpentier C: The impact of microbiological diagnostics on the antimicrobial treatment of hospitalised patients with infectious disease. Eur J Med Res 1:312-314, 1996.
23. Ballow CH: Cost considerations in oral antibiotic therapy. Advances in Therapy 12(2):199-206, 1995.
24. Nightingale CH: Cost of oral antibiotic therapy. Pharmacotherapy 17(2):302-307, 1997.
25. Grob PR: Antibiotic prescribing practices and patient compliance in the community. Scand J Infect Dis 83:7-14, 1992.
26. Jordan WC: Doxycycline vs tetracycline in the treatment of men with gonorrhea: The compliance factor. Sex Transm Dis 8(suppl 2):S105-S109, 1981.
27. Eisen SA, Miller DK, Woodward RS, et al: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150:1881-1884, 1990.
28. Greenberg RN: Overview of patient compliance with medication dosing: A literature review. Clin Ther 6:592-599, 1984.
29. Vogel F, Charpentier C: Derzeitige Ther apieempfehlungen bei Atemwegsinfektionen. Paul Ehrlich Gesellschaft Guidelines, 1998. In press.